University of Illinois Chicago
Chicago, Illinois, 60612, United States
Location status: Recruiting
NCT Number: NCT05792852
This is a single-arm community-based feasibility study examining recruitment, retention, adherence, and satisfaction with ENGAGE, a community-based intervention designed to address pandemic-related social isolation among people with disabilities. We will also examine preliminary, within-group effects on social participation. The findings of this study will inform a larger trial to examine intervention efficacy.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Chicago, Illinois, 60612, United States
Location status: Recruiting
Social isolation has been shown to negatively affect physical and mental health, particularly among people with disabilities. Social isolation among people with disabilities has been exacerbated by the COVID-19 pandemic. Even now, people with disabilities remain hesitant to return to social and community activities due to ongoing risk of severe cases and death. Yet, we do not have strong models of intervention designed to address this problem.
ENGAGE is an intervention that may address this gap. ENGAGE was designed to address social and community participation among people with stroke. We have since conducted qualitative research to inform adaptation of ENGAGE to meet the needs of a broader range of people with disabilities related to participation in the context of the ongoing COVID-19 pandemic. This study is the next step in testing and refining the adapted intervention protocol. At the end of this study, we will have a finalized adapted intervention protocol ready for large-scale efficacy testing.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
ENGAGE is a group intervention designed to improve social participation within the context of the COVID-19 pandemic.
Time frame: 8 weeks
Recruitment (5-7 participants per group recruited within one month), retention (80% of participants complete follow up assessments), adherence (80% of participants complete the intervention group
Time frame: 8 weeks
Client Satisfaction Questionnaire-8: 8-item scale of intervention satisfaction with a 32-point scale (higher scores indicate greater satisfaction). We will establish adequate acceptability if we achieve a mean score of 24 or greater.
Time frame: 8 weeks
PROMIS Ability to Participate in Social Roles (Cohen's d=/> .2)
Contact information is provided by the study sponsor or research team.
Jessica Kersey, PhD
CONTACT
Joy Hammel, PhD
CONTACT
University of Illinois at Chicago
Other
Feasibility of ENGAGE to Address Social Isolation Related to the COVID-19 Pandemic
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07699341
Airway Obstruction, Disabilities Multiple
Adıyaman, Turkey (Türkiye)
View Trial DetailsNCT05761847
Behavior, Child, Only
Aurora, Colorado, United States
View Trial DetailsNCT06608758
Disabilities Multiple
Chicago, Illinois, United States
View Trial DetailsNCT06104384
Behavior, Chronic Pain
Surrey, British Columbia, Canada
View Trial Details